SAN DIEGO, March 10, 2017 -- CUBA Beverage Company (OTC:CUBV) is excited to be participating in the 37th Annual Natural Products Expo West with its new all-natural alkaline spring water with a natural pH of 7.8.
The Natural Products Expo West is the largest natural, organic and healthy products conference in the world. Expo West 2017 will be held from March 8, 2017 to March 12, 2017 at the Anaheim Convention Center, Anaheim Marriot and Anaheim Hilton in Anaheim, CA. The Natural Products Expo West trade show is the leading trade show and is one of the largest natural, organic and healthy products conferences in the world.
This will be an excellent opportunity for Cuba Beverage Company to present its new 100% Natural Alkaline Water to the nation’s top distributors, wholesalers and retailers.
“With the launch of our bottled water product, we expect to attract new investment in the company, and it is our goal to become the number one bottled alkaline water in the United States,” said company CEO Alex Procopio.
Alkaline water is currently in high demand as it helps balance the body's pH, which tends to be acidic because of the high acid content in the typical food diet, stress and exposure to environmental toxins.
The Cuba Beverage Company water is bottled right at the source in the United States and is derived from 15,000-year-old Ice Age glaciers, which produces this pure, natural alkaline water. The alkaline water is UV treated and micron filtered to ensure the highest quality level.
“Our natural alkaline mineral spring water has no sugars, no stimulants and no artificial ingredients with zero calories, cholesterol or carbs. It offers refreshing taste with one of the highest natural 7.8 + pH factors available in the world, as well as naturally occurring electrolytes,” added Procopio.
Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
CONTACT: Investor Relations, 866-431-CUBA (2822)


Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 



